Charles River Laboratories

Charles River Laboratories, Curigin partner on gene therapy
Pharmaceutical Business Review
Tue, 06/13/23 - 10:41 am
Charles River Laboratories
Curigin
gene therapy
RNA
Charles River Laboratories has been on an acquisition spree. But Tuesday, it offloaded two assets
Endpoints
Wed, 10/13/21 - 10:53 am
Charles River Laboratories
M&A
gene therapy
CDMOs
Charles River lays out $293M to snap up viral vector specialist Vigene, its 2nd M&A deal this year
Fierce Pharma
Mon, 05/17/21 - 10:43 pm
Charles River Laboratories
M&A
CDMO
Vigene
Charles River pens Takeda early-stage drugs deal
Fierce Biotech
Mon, 01/13/20 - 10:53 am
JPMHC 2020
Charles River Laboratories
Takeda
Charles River Laboratories wraps up $380m acquisition of HemaCare
Pharmaceutical Business Review
Mon, 01/6/20 - 10:25 am
Charles River Laboratories
HemaCare
M&A
cell therapy
Charles River Labs to buy HemaCare for $380M, expands in cell therapy market
Biopharma Dive
Thu, 12/19/19 - 06:13 pm
Charles River Laboratories
CRO
HemaCare
cell therapy
M&A
Charles River 'reaffirms' commitment to tough neuroscience beat
Fierce Biotech
Mon, 10/7/19 - 11:07 am
Charles River Laboratories
Neuroscience
Alzheimer's disease
Charles River plots 2020 opening of South San Francisco lab
Fierce Biotech
Wed, 07/10/19 - 10:33 am
Charles River Laboratories
San Francisco
drug development
Charles River Labs Hit by Hackers, Some Client Data Compromised
BioSpace
Wed, 05/1/19 - 11:43 pm
Charles River Laboratories
cybersecurity
hacking
Billions of Dollars This Week Show AI Is in BioPharma’s Present and Future
BioSpace
Sat, 01/12/19 - 11:23 am
artificial intelligence
Atomwise
Charles River Laboratories
Beta Bionics
Elevian
Insilico
Lawsuit Alleges Racial Discrimination at Charles River Laboratories S.C. Facility
BioSpace
Tue, 11/20/18 - 12:10 pm
Charles River Laboratories
CROs
racial discrimination
Charles River buys KWS BioTest for $20M, gaining immunology discovery capacity and a UK footprint
Endpoints
Thu, 01/11/18 - 09:53 am
Charles River Laboratories
KWS BioTest
M&A
immunology
R&D
Charles River Laboratories International Inc. Agrees to Pay United States $1.8 Million to Settle False Claims Act Allegations
Department of Justice
Tue, 03/14/17 - 04:49 pm
Charles River Laboratories
False Claims Act
DOJ
NIH
Charles River bags new testing tech in $212M buyout
Fierce Biotech
Thu, 07/9/15 - 07:44 pm
Charles River Laboratories
Celsis
M&A
CROs rally after AstraZeneca rejects final bid from Pfizer
The Fly on the Wall
Mon, 05/19/14 - 10:30 am
CROs
AstraZeneca
Pfizer
M&A
Charles River Laboratories
Parexel
Covance
3 Rising Healthcare Stocks to Watch Now
Wall Street Cheat Street
Sun, 08/4/13 - 11:24 am
Bruker
Cempra
Charles River Laboratories
10 Biotech Stocks With A History Of Beating Earning Expectations
TheStreet.com
Fri, 01/11/13 - 12:14 pm
Alexion
Regeneron
Optimer
Targacept
Osiris
Array Biopharma
YM BioSciences
Questcor Pharmaceuticals
Charles River Laboratories
Illumina
Strengthening Moats Mean Improving Returns For CRO Investors
Seeking Alpha
Mon, 12/31/12 - 11:27 am
CROs
Charles River Laboratories
ICON
Will These Numbers from Charles River Laboratories International Be Good Enough for You?
Motley Fool
Sat, 10/27/12 - 11:28 am
Charles River Laboratories
CRL/AstraZeneca Join Forces
Yahoo/Zacks
Sat, 10/20/12 - 10:27 am
Charles River Laboratories
AstraZeneca

Pages